Risperdal (Risperidone) is an antipsychotic drug created by Johnson & Johnson. The drug was first approved by the FDA for the treatment of schizophrenia in adults and adolescents in 1993 and has since been approved for other "off-label" uses, as well. Those diagnosed with biopolar disorder, autism, ADHD, and other conditions have prescribed Risperdal by doctors to treat symptoms.
Although the drug has made Johnson & Johnson billions of dollars over the years, some patients have suffered traumatic side effects after beginning use.
Breast Development in Male Children
While the goal of Risperdal is to alter chemicals in the brain, many male children and adolescents can experience adverse physical reactions. Male breast tissue enhancement, a condition known as gynecomastia, has been shown to develop more with Risperdal use, than other antipsychotic medications. The condition can be both emotionally and physically scarring, with some boys requiring mastectomies.
Johnson & Johnson has claimed to have provided adequate warnings with their Risperdal prescriptions. They have also blamed the gynecomastia side effect on puberty, claiming that breast development is normal in young men.
Your Legal Options
Despite Johnson & Johnson's claims, breast enlargement requiring surgical removal is not normal for pubescent boys. Hundreds of lawsuits have been filed against the company by individuals who claim to have suffered emotional and psychological trauma from breast growth associated with taking the drug. If you or a loved one are one of these individuals, do not hesitate to contact Brayton Purcell L.L.P. today Here.